High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease

NCT00461604 · clinicaltrials.gov ↗

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Patients With Persistent Objectified Gastroesophageal Reflux and Reflux-Associated Symptoms Despite PPI-Therapy With 40mg Esomeprazole

Sponsor

Technical University of Munich